BCG immunotherapy - From pathophysiology to clinical practice

Moshe Tishler; Yehuda Shoenfeld

doi:10.1517/14740338.5.2.225

BCG immunotherapy - From pathophysiology to clinical practice

Moshe Tishler, Yehuda Shoenfeld^*

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Abstract

Treatment with Bacillus Calmette-Guérin vaccine is mainly in use for superficial bladder cancer, for which it is given intravesically. Overall, this therapy is safe with only minor side effects. Arthritis secondary to such therapy has been rarely reported and usually responds well to NSAID treatment. The mechanisms leading to such a complication, as well as the clinical data, are discussed.

Original language	English
Pages (from-to)	225-229
Number of pages	5
Journal	Expert Opinion on Drug Safety
Volume	5
Issue number	2
DOIs	https://doi.org/10.1517/14740338.5.2.225
State	Published - Mar 2006

Keywords

Arthritis
Autoimmunity
BCG vaccination

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1517/14740338.5.2.225

Cite this

@article{e2387346decd434db72603cf23e94432,

title = "BCG immunotherapy - From pathophysiology to clinical practice",

abstract = "Treatment with Bacillus Calmette-Gu{\'e}rin vaccine is mainly in use for superficial bladder cancer, for which it is given intravesically. Overall, this therapy is safe with only minor side effects. Arthritis secondary to such therapy has been rarely reported and usually responds well to NSAID treatment. The mechanisms leading to such a complication, as well as the clinical data, are discussed.",

keywords = "Arthritis, Autoimmunity, BCG vaccination",

author = "Moshe Tishler and Yehuda Shoenfeld",

year = "2006",

month = mar,

doi = "10.1517/14740338.5.2.225",

language = "אנגלית",

volume = "5",

pages = "225--229",

journal = "Expert Opinion on Drug Safety",

issn = "1474-0338",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - BCG immunotherapy - From pathophysiology to clinical practice

AU - Tishler, Moshe

AU - Shoenfeld, Yehuda

PY - 2006/3

Y1 - 2006/3

N2 - Treatment with Bacillus Calmette-Guérin vaccine is mainly in use for superficial bladder cancer, for which it is given intravesically. Overall, this therapy is safe with only minor side effects. Arthritis secondary to such therapy has been rarely reported and usually responds well to NSAID treatment. The mechanisms leading to such a complication, as well as the clinical data, are discussed.

AB - Treatment with Bacillus Calmette-Guérin vaccine is mainly in use for superficial bladder cancer, for which it is given intravesically. Overall, this therapy is safe with only minor side effects. Arthritis secondary to such therapy has been rarely reported and usually responds well to NSAID treatment. The mechanisms leading to such a complication, as well as the clinical data, are discussed.

KW - Arthritis

KW - Autoimmunity

KW - BCG vaccination

UR - http://www.scopus.com/inward/record.url?scp=33644891874&partnerID=8YFLogxK

U2 - 10.1517/14740338.5.2.225

DO - 10.1517/14740338.5.2.225

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

AN - SCOPUS:33644891874

SN - 1474-0338

VL - 5

SP - 225

EP - 229

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

IS - 2

ER -

BCG immunotherapy - From pathophysiology to clinical practice

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this